Reaction
Tissue Infiltration reporting signals
As of the last recalculation, Tissue Infiltration appears in 289 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 268.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bleomycin Sulfate | 34 | 268.5 | 269.4 |
| Valsartan Oral | 40 | 61.4 | 61.4 |
| Azacitidine For | 14 | 58.2 | 58.2 |
| Posaconazole Delayed-Release | 8 | 53.9 | 54.0 |
| Meropenem | 18 | 43.0 | 43.0 |
| Etoposide | 36 | 40.1 | 40.2 |
| Azacitidine | 14 | 35.7 | 35.7 |
| Pegfilgrastim | 36 | 29.9 | 29.9 |
| Dabrafenib | 8 | 28.1 | 28.1 |